|
Atomistry » Chlorine » PDB 4n9a-4ngr » 4ncg | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Chlorine » PDB 4n9a-4ngr » 4ncg » |
Chlorine in PDB 4ncg: Discovery of Doravirine, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv VirusesEnzymatic activity of Discovery of Doravirine, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses
All present enzymatic activity of Discovery of Doravirine, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses:
2.7.7.49; 2.7.7.7; 3.1.13.2; 3.1.26.13; Protein crystallography data
The structure of Discovery of Doravirine, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses, PDB code: 4ncg
was solved by
Y.Yan,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 4ncg:
The structure of Discovery of Doravirine, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses also contains other interesting chemical elements:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Discovery of Doravirine, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses
(pdb code 4ncg). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Discovery of Doravirine, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses, PDB code: 4ncg: Chlorine binding site 1 out of 1 in 4ncgGo back to![]() ![]()
Chlorine binding site 1 out
of 1 in the Discovery of Doravirine, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses
![]() Mono view ![]() Stereo pair view
Reference:
B.Cote,
J.D.Burch,
E.Asante-Appiah,
C.Bayly,
L.Bedard,
M.Blouin,
L.C.Campeau,
E.Cauchon,
M.Chan,
A.Chefson,
N.Coulombe,
W.Cromlish,
S.Debnath,
D.Deschenes,
K.Dupont-Gaudet,
J.P.Falgueyret,
R.Forget,
S.Gagne,
D.Gauvreau,
M.Girardin,
S.Guiral,
E.Langlois,
C.S.Li,
N.Nguyen,
R.Papp,
S.Plamondon,
A.Roy,
S.Roy,
R.Seliniotakis,
M.St-Onge,
S.Ouellet,
P.Tawa,
J.F.Truchon,
J.Vacca,
M.Wrona,
Y.Yan,
Y.Ducharme.
Discovery of Mk-1439, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses. Bioorg.Med.Chem.Lett. V. 24 917 2014.
Page generated: Sun Jul 21 20:38:13 2024
ISSN: ISSN 0960-894X PubMed: 24412110 DOI: 10.1016/J.BMCL.2013.12.070 |
Last articlesZn in 9J0NZn in 9J0O Zn in 9J0P Zn in 9FJX Zn in 9EKB Zn in 9C0F Zn in 9CAH Zn in 9CH0 Zn in 9CH3 Zn in 9CH1 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |